These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Molecular modelling studies unveil potential binding sites on human serum albumin for selected experimental and Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM; Sami H Saudi J Biol Sci; 2022 Jan; 29(1):53-64. PubMed ID: 34548836 [TBL] [Abstract][Full Text] [Related]
26. Flavonoid compounds of buah merah ( Umar AK Futur J Pharm Sci; 2021; 7(1):158. PubMed ID: 34395638 [TBL] [Abstract][Full Text] [Related]
27. Computational study of the therapeutic potentials of a new series of imidazole derivatives against SARS-CoV-2. Johnson TO; Adegboyega AE; Iwaloye O; Eseola OA; Plass W; Afolabi B; Rotimi D; Ahmed EI; Albrakati A; Batiha GE; Adeyemi OS J Pharmacol Sci; 2021 Sep; 147(1):62-71. PubMed ID: 34294374 [TBL] [Abstract][Full Text] [Related]
28. In silico Studies on the Interaction between Mpro and PLpro From SARS-CoV-2 and Ebselen, its Metabolites and Derivatives. Nogara PA; Omage FB; Bolzan GR; Delgado CP; Aschner M; Orian L; Teixeira Rocha JB Mol Inform; 2021 Aug; 40(8):e2100028. PubMed ID: 34018687 [TBL] [Abstract][Full Text] [Related]
29. Targeting Neurological Manifestations of Coronaviruses by Candidate Phytochemicals: A Mechanistic Approach. Fakhri S; Piri S; Majnooni MB; Farzaei MH; Echeverría J Front Pharmacol; 2020; 11():621099. PubMed ID: 33708124 [TBL] [Abstract][Full Text] [Related]
30. The pulmonary route as a way to drug repositioning in COVID-19 therapy. Sarcinelli MA; Martins da Silva T; Artico Silva AD; Ferreira de Carvalho Patricio B; Mendes de Paiva FC; Santos de Lima R; Leal da Silva M; Antunes Rocha HV J Drug Deliv Sci Technol; 2021 Jun; 63():102430. PubMed ID: 33649708 [TBL] [Abstract][Full Text] [Related]
31. Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication. Oudshoorn D; Rijs K; Limpens RWAL; Groen K; Koster AJ; Snijder EJ; Kikkert M; Bárcena M mBio; 2017 Nov; 8(6):. PubMed ID: 29162711 [TBL] [Abstract][Full Text] [Related]
32. The potential of Paritaprevir and Emetine as inhibitors of SARS-CoV-2 RdRp. Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM Saudi J Biol Sci; 2021 Feb; 28(2):1426-1432. PubMed ID: 33281478 [TBL] [Abstract][Full Text] [Related]
33. Gurung AB; Ali MA; Lee J; Abul Farah M; Al-Anazi KM Saudi J Biol Sci; 2020 Oct; 27(10):2674-2682. PubMed ID: 32837219 [TBL] [Abstract][Full Text] [Related]
34. Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme. Bahadur Gurung A; Ajmal Ali M; Lee J; Abul Farah M; Mashay Al-Anazi K J King Saud Univ Sci; 2020 Sep; 32(6):2845-2853. PubMed ID: 32837113 [TBL] [Abstract][Full Text] [Related]
36. Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug. Wang YC; Yang WH; Yang CS; Hou MH; Tsai CL; Chou YZ; Hung MC; Chen Y Am J Cancer Res; 2020; 10(8):2535-2545. PubMed ID: 32905393 [TBL] [Abstract][Full Text] [Related]